IL1B and diabetic kidney disease: In rats with a DKD model induced by streptozotocin, Fang et al.38 demonstrated that plasma TMAO levels were high in rats with DKD, and theyshowed worsening of kidney functions, fibrosis, and inflammation, and anincrease in IL-1b and IL-18 secretion were observed with the administration ofTMAO.